Instituto Médico Especializado Alexander Fleming

Buenos Aires, Ciudad Autónoma de Buenosaires CP1426ANZ

0 studies enrolling now · 2 studies all time

What they study most

Brain Metastases, Melanoma

Studies at this site

• Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma — Completed
• An Open-Label, Randomized, Multicenter Trial of Encorafenib + Binimetinib Evaluating a Standard-dose and a High-dose Regimen in Patients With BRAFV600-mutant Melanoma Brain Metastasis — Stopped early